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ABSTRACT 
We present a case of a gravida 1 para 1  woman, who presented with an 11-
month history of amenorrhea after cesarean delivery. The patient was taking 
birth control pills at the time of presentation. She was observed with a slight 
elevation of serum β-hCG level, an enlarged heterogeneous uterus and 
hematometra. A biopsy was performed, and the patient was diagnosed with 
placental site trophoblastic tumor; the patient then underwent surgery. 
Placental site trophoblastic tumor is the rarest form of gestational 
trophoblastic disease, derived from intermediate trophoblast cells. It does not 
have a pathognomonic appearance; therefore, correlation with medical 
history, as well as results of laboratory tests and pathological analysis is 
mandatory. It is a relatively chemoresistant tumor, posing considerable 
therapeutic challenges; patients with localized disease are managed with 
surgery and those with metastatic disease require additional chemotherapy. 
Herein, we review the main features of this entity and top differential 
diagnosis, as the rarity of this tumor is associated with imaging and 
pathological pitfalls, reinforcing the need for further experience in this field. 
 
 
 
 
CASE REPORT 
 
 
 
 
 
 
A 34-year-old gravida 1 para 1 woman, presented with 
amenorrhea after her recent delivery via caesarean section 11 
months previously. Amenorrhea was initially attributed to 
progestin-only contraceptives (desogestrel, 75µg, daily) that 
the patient had been consuming during 6 months of 
breastfeeding. Despite ceasing hormonal therapy and changing 
to combined estrogen-progestin contraceptive pills 
(drospirenone [3mg] and ethinyloestradiol [0.03mg] daily for 
21 days followed by a 7 day break), which the patient had been 
consuming prior to pregnancy and was comfortable with, her 
amenorrhea persisted. 
Gynecologic examination was unremarkable and physical 
examination revealed only right lower quadrant abdominal 
pain.  
 
Serum β-hCG (human chorionic gonadotropin) level was 
slightly elevated at 68.4mIU/mL, and all other routine 
laboratory test results were within normal limits. 
 
 
Imaging findings  
Transabdominal and transvaginal ultrasonography images 
(Fig. 1) revealed an enlarged retroverted uterus, measuring 
90x67x45mm in the longitudinal, transverse, and antero-
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posterior axes. The endometrial cavity was filled with fluid 
and debris (hematometra) and no endometrial thickening was 
identified. No myometrial nodular lesions were observed, 
although the myometrial echotexture was diffusely 
heterogeneous. Both ovaries were normal. 
 
Pelvic magnetic resonance (MR) imaging revealed a 
normal diffuse low-intensity myometrial signal on T1-
weighted images, and moderate hyperintensity of the uterine 
myometrium, with loss of zonal uterine anatomy, on T2-
weighted images. (Fig. 2A-2C). On dynamic T1-weighted 
post-contrast images, the uterine body moderately enhanced, 
although to a lesser degree than the cervix (Fig. 2D) and it 
showed a high signal on diffusion-weighted images with a low 
signal on the ADC map (Fig. 3). 
 
 
Management  
The initial endometrial suction curettage specimen was 
not adequate for histological or immunohistochemical 
characterization. Therefore, endometrial sampling via 
resectoscopy was performed, which was complicated by 
uterine wall perforation.  
 
A laparotomy was immediately performed to thoroughly 
evaluate the abdominal and pelvic cavities, and a palpable 
uterine wall lesion was detected and biopsied. The histological 
examination revealed intermediate trophoblastic cells with 
scant hyalinization, moderate atypia, and sparse hemorrhage.  
 
The immunohistochemical evaluation was positive for α-
inhibin, cytokeratin CAM 5.2, placental lactogenic hormone, 
and p63; it was only focally positive for β-hCG, with a Ki-67 
index of 9%, supporting the diagnosis of placental site 
trophoblastic tumor (PSTT). 
 
The patient underwent hysterectomy with ovarian 
conservation and bilateral pelvic lymphadenectomy.  
 
The final pathology report confirmed the diagnosis of 
PSTT, revealing an enlarged uterus measuring 9.5cm along the 
long axis. Most of the uterine body was substituted by a 
yellowish tumor that infiltrated almost the entire myometrial 
thickness, without invading the cervix (Fig. 4). The serosa was 
intact, and no lymph node metastases were observed. The 
endometrial cavity was irregularly delineated and filled with 
blood clots. Microscopic evaluation revealed intermediate 
trophoblastic cells with moderate nuclear pleomorphism 
invading the myometrium (Fig. 5). 
 
 
Follow-up  
One month after surgery, the β-hCG level was <1mIU/mL. 
 
At the time of the study, the patient had been in remission 
for 9 months without adjuvant chemotherapy, and she was 
undergoing monthly serum β-hCG follow-up evaluations. 
 
 
 
 
 
 
Etiology and demographics 
Gestational trophoblastic disease represents a wide 
spectrum of proliferative disorders characterized by 
proliferation of trophoblasts, including premalignant and 
malignant lesions [1].  
 
PSTT is a slow-growing malignant monomorphic tumor 
that arises from placental intermediate trophoblasts, which are 
responsible for embryo implantation, and have features of both 
cytotrophoblasts and syncytiotrophoblasts [2,3]. 
 
Kurman and Scully first described this tumor it in 1976, 
under the term trophoblastic pseudotumor in accordance with 
the apparent benign nature of this lesion [4]. With further 
evidence of its malignant behavior, the nomenclature was 
changed to PSTT in 1981, and it has since then been adopted 
by the World Health Organization [5].  
 
PSTT is the rarest subtype of gestational trophoblastic 
disease, with an incidence of approximately 1-5 per 100,000 
pregnancies, accounting for approximately 0.2% of all cases, 
as suggested by population-based studies [1,6,7].  
 
Because of the rarity of this type of tumor, the current 
medical knowledge is mainly based on the results of a few 
published trophoblastic disease center series [1,6-12] and 
sparse reports of small series or singular cases [13-16]. 
 
PSTT mostly affects women of reproductive age (the 
average age at presentation is 32-35 years)  [1,11,12], and it is 
usually diagnosed following a normal or ectopic pregnancy, 
miscarriage, or gestational trophoblastic disease [6,7,12]. 
However, its occurrence in post-menopausal women has also 
been described [6].  
 
Risk factors for PSTT are still not well understood. 
 
 
Clinical presentation 
The most common presenting symptom is irregular 
vaginal bleeding, followed by abdominal pain and amenorrhea 
[1]. Less frequent presentations include galactorrhea, 
virilization, nephrotic syndrome, polycythemia and symptoms 
related to the metastatic involvement of distant organs 
including the brain and lungs [6]. 
 
Laboratory and pathological diagnosis 
In most patients with PSTT, serum levels of β-hCG are 
not highly elevated, which differs from other forms of 
gestational trophoblastic disease, as this tumor originates from 
intermediate trophoblastic cells. On the other hand, the 
expression of human placental lactogen (hPL) is usually high 
on histological sections and in the serum, and upregulation of 
b1-glycoprotein and CA-125 is also common [17]. 
 
Pathological evaluation is necessary for a definite 
diagnosis of PSTT, although it is not always sufficient; 
therefore, expertise in this field is critical to avoid incorrect 
diagnosis and therapeutic intervention [12]. 
DISCUSSION 
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16 
In the present case, as the patient was taking hormonal 
birth control pills, the amenorrhea could have represented the 
absence of withdrawal bleeding related to hormonal side 
effects, and this could have contributed to the delay in the 
diagnosis.  
 
 
Imaging findings  
A small number of reports have described the imaging 
findings characteristic of PSTT [15,16,18-22].   
 
On ultrasonography images, a solid mass within the 
endometrial cavity or in the myometrium may be identified, 
with more or less prominent blood vessels on color Doppler 
imaging. In certain cases, as in the present patient, no obvious 
abnormality is observed besides an enlarged uterus with a 
heterogeneous echotexture with echogenic foci and cystic 
areas of hemorrhage, reflecting the lack of sensitivity and 
specificity of this technique in this setting [20-23]. 
 
The role of computed tomography (CT) is limited to the 
detection of metastatic disease [21]. 
 
On MR imaging, PSTT has a nonspecific appearance. A 
frequent observation is the distortion of the junctional zone 
caused by a myometrial or endometrial mass, which is 
typically isointense to normal myometrium on T1-weighted 
images and isointense to slightly hyperintense to the 
myometrium on T2-weighted images; a diffusely 
heterogeneous pattern of the uterus with loss of zonal anatomy 
is also observed [15,18].  
 
Two different vascular patterns of PSTT have been 
described, as follows: the hypervascular type, which is 
associated with numerous signal voids and marked dilatation 
of gonadal vessels, and enhances avidly after contrast 
administration; and the hypovascular type, which is typically 
smaller in size, and is hyperintense to normal myometrium on 
both T1- and T2-weighted images, with moderate 
enhancement after gadolinium administration [17,19], as in the 
present case.   
 
The tumor is usually confined to the uterine body, but can 
extend into adjacent organs such as the ovary, parametrium, 
rectum or bladder and can involve lymph nodes, before 
metastasizing to lung, liver, brain and other organs. Metastases 
can occur years after the diagnosis [6,17].   
 
 
Differential diagnosis 
The differential diagnosis is made with other malignant 
forms of gestational trophoblastic disease, particularly invasive 
moles and choriocarcinoma, but also trophoblastic 
proliferations, which regress spontaneously [17]. 
 
Invasive moles are locally invasive nonmetastatic 
neoplasms that affect approximately 10% of women after 
undergoing treatment for complete (or partial) hydatidiform 
mole. The usual presentation includes persistently elevated β-
hCG levels, and ultrasonography may reveal an enlarged 
uterus with a heterogeneous echogenic mass and multiple tiny 
cystic foci corresponding to hydropic villi rather than 
hemorrhagic areas. Occasionally, myometrial invasion and 
even uterine wall perforation are observed [3]. The 
characteristic finding on MR imaging is a poorly defined mass 
with predominantly low signal intensity on T1-weighted 
images, high signal intensity on T2-weighted images and avid 
enhancement [24].  
 
Choriocarcinomas usually develop from a complete 
hydatidiform mole, but can also occur after a normal 
pregnancy or abortion and can metastasize. They are 
characterized by elevated β-hCG levels and an enlarged uterus. 
Tumor margins are characteristically nodular and well defined. 
MR imaging shows a wide spectrum of appearances, reflecting 
the degree of hemorrhage and necrosis. After contrast 
administration, the enhancement of the solid periphery of the 
tumor is lower than that observed in an invasive mole 
[3,12,18]. 
 
Trophoblastic proliferations regressing spontaneously are 
nodular or plaque-like trophoblastic benign lesions that are 
typically circumscribed and smaller than PSTTs. However, to 
the best of our knowledge, little is known about the imaging 
features of these entities and the differential diagnosis is 
mainly based on pathological analysis showing mitotic 
inactivity [25]. 
 
 
Treatment and prognosis 
In contrast to other trophoblastic tumors, PSTT is 
relatively insensitive to chemotherapy, and surgery is the 
primary therapeutic approach in patients presenting with 
disease limited to the uterus [1]. 
 
Patients with uterine-confined disease may be managed by 
hysterectomy, whereas those with metastatic disease at the 
time of diagnosis cannot be cured by surgery alone, and they 
require combination chemotherapy [7]. 
 
In premenopausal women, the standard practice is to 
preserve the ovaries unless there is evidence of ovarian disease 
or the patient has a family history of ovarian cancer. Some 
studies support focal resection of localized uterine disease to 
preserve fertility [14], however there is a risk of treatment 
failure because of the dissemination of microscopic disease 
through the rest of the uterus [26, 27]. 
 
Although most patients with PSTT can be cured, a 
recurrence rate of approximately 30% has been reported [7]. 
 
There is a lack of consensus in the literature regarding the 
key prognostic factors for PSTT. The largest retrospective 
study recently published concluded that the only significant 
independent predictor of survival was the time interval 
between the preceding pregnancy and diagnosis. In that study, 
the results of an extensive multivariate analysis indicated a cut-
off point of 48 months or more as a predictor of poor 
prognosis [7]. 
 
Others studies suggested that tumor stage is the most 
important prognostic feature [1,6], and some researchers 
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suggested an association between poor prognosis and factors 
such as a high-risk score, high β-hCG levels (>10,000 UI/L), 
age ≥40 years, or high mitotic index [6,7]. 
 
Although PSTT produces only small amounts of β-hCG 
and no correlation between serum β-hCG levels and tumor 
burden or malignant behavior has been observed, indicating its 
poor predictive value, it is the best available serum marker for 
monitoring response to treatment and follow-up [6,13]. 
 
 
 
 
 
Placental site trophoblastic tumor is a rare, chemoinsensitive, 
gestational trophoblastic tumor characterized by the lack of 
significantly elevated β-hCG levels and commonly associated 
with amenorrhea or irregular bleeding. The diagnosis is not 
always straightforward, and MR imaging represents a useful 
tool when the results of other modalities are indeterminate, 
although a high level of clinical suspicion is still required. 
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Figure 1: Ultrasonography images of the uterus of a 34-year-old female patient with placental site trophoblastic tumor. 
Transabdominal sonography with a 5-MHz curvilinear probe, midline sagittal transabdominal view (1A); and transvaginal 
sonography with a 10-MHz endocavitary probe, midline sagittal view (1B) depict an acutely retroverted uterus measuring 
90×67×45mm in the longitudinal longitudinal, transverse and antero-posterior axes, with diffuse heterogeneous myometrial 
echotexture and hematometra distending the endometrial cavity. Note the irregular contour of the endometrial cavity in the fundus 
region (white arrow).  
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Figure 2: Pelvic magnetic resonance images of a 34-year-old female patient with placental site trophoblastic tumor.   
Axial T1-weighted image (2A) reveals hyperintense filling of the endometrial cavity related to the presence of blood (white 
arrow). Axial oblique (perpendicular to the long axis of endometrial cavity) (2B) and sagittal (2C) T2-weighted images reveal 
heterogeneous hypersignal of the myometrium of the uterine corpus (asterisk), with loss of the zonal anatomy (white arrowhead). 
On a sagittal T1-weighted dynamic contrast-enhanced MR image obtained 2 minutes after contrast medium injection (2D), the 
tumor enhances to a lesser degree (white circle) than the normal cervix. 
[Philips Intera Pulsar 1.5T: T1-weighted images (TR=566; TE=10); T2-weighted images (TR=3500; TE=90); Dynamic contrast-
enhanced MR image obtained with a three-dimensional gradient-recalled echo T1-weighted sequence (TR=5.6; TE=2.8), with fat 
suppression and after the administration of 0.1mmol/kg of gadopentetate dimeglumine at a rate of 2mL/sec acquired 2 minutes 
after injection]. 
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Figure 3: Diffusion-weighted magnetic resonance (MR) images of the uterus of a 34-year-old female patient with placental site 
trophoblastic tumor.  
In the axial diffusion-weighted MR image (b=1000sec/mm
2
) (3A), the tumor shows high signal intensity with deep myometrial 
invasion (black asterisk).  
In the axial apparent diffusion coefficient (ADC) map (3B), the area of high signal intensity in the diffusion-weighted MR image 
shows low signal intensity, a finding that is consistent with restricted diffusion (white asterisk). 
Note the high intensity of the endometrial cavity in the diffusion-weighted MR image (black arrowhead) and the corresponding 
low intensity on the ADC map (white arrowhead) related to the presence of blood products causing marked restriction.  
[Philips Intera Pulsar 1.5T: Axial diffusion-weighted images (TR=2500; TE=70,9); flip angles of 90º, performed with b values of 
1000sec/mm
2
]. 
 
 
 
Figure 4: Specimen obtained from the uterus of a 34-year-old female patient with placental site trophoblastic tumor.  
Macroscopic pathologic features (4A, 4B) reveal an infiltrating yellowish-white tumor with irregular contours that invades the 
whole thickness of the myometrium and projects into the endometrial cavity, without reaching the cervix. The tumor margin 
(yellow demarcation line in 4B) does not extend to the uterine serosa.  
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Etiology Unknown 
Incidence 1–5 per 100,000 pregnancies 
Gender ratio Women 
Age predilection 3
rd
 decade 
Risk factors Unknown 
Treatment Hysterectomy for localized disease; 
Hysterectomy plus chemotherapy for advanced disease 
Prognosis Remains uncertain 
May depend on time since preceding pregnancy and diagnosis 
Findings on 
imaging 
Ultrasound 
Enlarged heterogeneous uterus, with echogenic areas and cystic foci; solid endometrial/myometrial lesion 
with more or less prominent blood vessels on color Doppler imaging. 
 
MRI 
Myometrial/endometrial mass:  
– hypervascular type: T1-WI isointense to normal myometrium; T2-WI slightly hyperintense with 
distortion of the junctional zone, numerous signal voids and marked dilatation of gonadal vessels; 
marked enhancement; 
– hypovascular type: usually smaller in size, hyperintense to normal myometrium on both T1 and T2-WI; 
moderate enhancement. 
 
Table 1: Summary table of placental site trophoblastic tumor characteristics. 
 
 
Figure 5: Sample of the uterus of a 34-year-old female patient with placental site trophoblastic tumor.   
[Photomicrograph showing intermediate trophoblastic cells with abundant eosinophilic cytoplasm and moderate nuclear 
pleomorphism, which deeply invades the myometrium. Hematoxylin and eosin stain, magnification: 5× (5A) and 10× (5B)]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Radiology Case. 2015 Apr; 9(4):14-22 
Obstetric & Gynecologic 
Radiology: 
Placental site trophoblastic tumor: a case report and review of the literature Lucas et al. 
Jo
u
rn
al
 o
f 
R
ad
io
lo
g
y
 C
as
e 
R
ep
o
rt
s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
  
     
w
w
w
.R
ad
io
lo
g
y
C
ases.co
m
 
22 
 US MR 
Placental site 
trophoblastic tumor 
 Enlarged heterogeneous uterus, with 
echogenic areas and cystic foci. 
 Solid endometrial/ myometrial lesion 
with more or less prominent blood 
vessels on color Doppler imaging. 
 
 Hypervascular tumor type: 
– T1-WI isointense. 
– T2-WI slightly hyperintense. 
– Avidly enhancing endometrial/ myometrial lesion 
with numerous signal voids and marked dilatation of 
gonadal vessels. 
 Hypovascular tumour type: 
– T1-WI and T2-WI hyperintense to normal 
myometrium. 
– Endometrial/myometrial lesion, smaller in size. 
– Moderate enhancement and absence of signal voids or 
prominent vascularity. 
 Capable of metastasizing (particularly to pelvic lymph 
nodes). 
Invasive mole  Heterogeneous, echogenic, 
hypervascular endometrial lesion. 
 
 Poorly defined intrauterine lesion that deeply invades 
the myometrium with evidence of disruption of the 
junctional zone. 
 T1-WI isointense with focal hyperintense areas within 
the myometrium (hemorrhage). 
 T2-WI mixed signal intensity, with tiny cystic inner 
structures related to the molar component. 
 Enhances intensely. 
 May be associated with dilated vessels within the 
tumor, myometrium and parametrium. 
 Locally invasive, nonmetastasizing.  
Choriocarcinoma  Heterogeneous lesion enlarging the 
uterus and resembling invasive mole 
associated with areas of necrosis and 
hemorrhage but may also manifest as a 
discrete central infiltrative lesion. 
 Usually markedly hypervascular on 
color Doppler imaging. 
 Intrauterine lesion with nodular well-defined margins. 
 T1WI isointense with focal hyperintense areas within 
the myometrium (hemorrhage). 
 T2-WI heterogeneous high signal (necrosis). 
Myometrial invasion is visible as high-signal-intensity 
foci within the myometrium, which demonstrate 
enhancement on postcontrast images. 
 Peripheral intense enhancement with a necrotic center. 
 Capable of metastasizing, frequently manifesting with 
lung and pelvic metastases. 
 
Table 2: Differential diagnosis table for placental site trophoblastic tumor. 
 
 
 
β-hCG = Human chorionic gonadotropin 
hPL = Human placental lactogen  
MR = Magnetic resonance  
PSTT = Placental site trophoblastic tumor 
US = Ultrasonography 
 
 
 
 
 
Placental site trophoblastic tumor; Gestational trophoblastic 
disease; Uterus; Ultrasound; Magnetic resonance 
 
 
 
 
 
Thanks to Dr. Rafael Cabrera for sharing the pathology results. 
 
 
Online access 
This publication is online available at: 
www.radiologycases.com/index.php/radiologycases/article/view/2146 
 
Peer discussion 
Discuss this manuscript in our protected discussion forum at: 
www.radiolopolis.com/forums/JRCR 
 
Interactivity 
This publication is available as an interactive article with 
scroll, window/level, magnify and more features. 
Available online at www.RadiologyCases.com 
 
Published by EduRad 
 
www.EduRad.org 
ABBREVIATIONS 
KEYWORDS 
ACKNOWLEDGEMENTS 
